Wanted: A policy for the ‘invisible’ rare diseases community

Avantika Shrivastava | Updated on June 21, 2019 Published on June 21, 2019

Earlier this month, Union Health Minister Harsh Vardhan chaired a high-level review meeting on non-communicable diseases. Also on the agenda was the reformulation of the national policy for treatment of rare diseases, which has been in abeyance since last year. An estimated 72-96 million Indians are affected by rare diseases. These millions have largely been invisible in policy-making and implementation.

Rare diseases are chronic illnesses that rob patients of their health and, in many cases, their lives. India has not arrived at an official consensus on the definition of a rare disease, but for others, such as the European Union, a disease is rare if it affects fewer than 5 in 10,000 people. About 80 per cent cases are genetic and half occur in childhood. However, rare diseases can strike at any point in a person’s lifetime, leaving them with crushing health worries, disability, and often exorbitant medical bills from mostly incurable conditions.

Rare diseases demand a comprehensive policy response, which India has been weak in offering. And a critical reason for that is funding.

Paucity of funds

The Centre provides financial assistance through the Rashtriya Arogya Nidhi (RAN) for patients below the poverty line. As part of the scheme, treatment and care for identified diseases can be accessed, but for the major part at 14 super-specialised hospitals concentrated in our top cities.

Now, consider this: a new drug developed for spinal muscular atrophy for children under 2 years of age (which causes progressive muscle weakness and can lead to death) approved by the United States Food and Drug Administration is set to cost upwards of $2 million. Medication available to Indians can also run into lakhs of rupees for particular diseases.

However, the sum utilised as part of RAN in financial year 2017-2018 was a little over ₹43 crore for a range of illnesses that also cover a handful of rare diseases in the tally of 450 illnesses recorded in the country.

Financial assistance as part of RAN is given as ‘one-time grants’, while rare illnesses require sustained medical attention. Health is a State subject but, as with the Union government, allocations for rare diseases by State governments seem low. Karnataka and Tamil Nadu have offered treatments for individual cases, and patient advocacy through courts has had a role to play in this.

Lack of infrastructure

There are more than 6,000 known rare diseases world over, and even in advanced countries such as the US, it can take an estimated seven years for a patient to be diagnosed with a rare disease. In the Indian context, lack of public infrastructure and trained staff limits proper diagnosis and reporting of cases. A simple question that stares us in the face is, are we doing enough to save lives by ensuring patients have what they need to survive and thrive?

Rare diseases are a matter of public health and people with such illnesses have not been given their due in policy creation and implementation. The current government has included rare diseases in its plan of action. With the upcoming Budget session, now is the chance to make good on its promise.

The writer hosts a podcast on

rare diseases and policy titled

“1 in 20,000” on Suno India

Published on June 21, 2019

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.